Key result
Impaired fasting glucose significantly predicted reduced survival compared to normal glucose levels in patients with heart failure (HR 1.55; 95% CI 1.13-2.15; P<0.01).
Why the study?
Does impaired fasting glucose predict reduced survival and increased cardiac hospitalizations in patients with heart failure?
Population
6,067 patients with a diagnosis of heart failure at a health maintenance organization in Jerusalem, Israel…
Comparison
Impaired fasting glucose and diabetes vs Normal fasting glucose levels (92-99 mg/dL)
Design
Cohort
Follow-up
mean 487 days
Authors
Loading...
May identify higher-risk HF patients for closer monitoring; leaves open whether intervention improves outcomes.
Cohort (n=6,067)
No
Does impaired fasting glucose predict reduced survival and increased cardiac hospitalizations in patients with heart failure?
Effect estimate: HR 1.55 (95% CI 1.13-2.15)
p-value: p=< 0.01
Impaired fasting glucose confers a similar risk of mortality and cardiac hospitalizations as overt diabetes in patients with heart failure.
Gotsman et al. (2014) conducted a cohort in Heart failure (n=6,067). Impaired fasting glucose (IFG) vs. Normal glucose levels (92-99 mg/dL) was evaluated on Survival (HR 1.55, 95% CI 1.13-2.15, p=< 0.01). Impaired fasting glucose significantly predicted reduced survival compared to normal glucose levels in patients with heart failure (HR 1.55; 95% CI 1.13-2.15; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: